|
United States Amyotrophic Lateral Sclerosis (ALS) Market Report 2019: Pipeline; Epidemiology; Market Valuations; Drugs, Sales, and Market Share (2014-2024)
Friday, July 12, 2019
DUBLIN, July 12, 2019 /PRNewswire/ -- The "US Amyotrophic Lateral Sclerosis Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
US Amyotrophic Lateral Sclerosis Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Amyotrophic Lateral Sclerosis pipeline products, Amyotrophic Lateral Sclerosis epidemiology, Amyotrophic Lateral Sclerosis market valuations and forecast, Amyotrophic Lateral Sclerosis drugs sales and competitive landscape in the US.
The research is classified into seven sections - Amyotrophic Lateral Sclerosis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
-- Amyotrophic Lateral Sclerosis pipeline: Find out the products in
clinical trials for the treatment of Amyotrophic Lateral Sclerosis by
development phase 3, phase 2, and phase 1, by pharmacological class and
companies developing the products
-- Amyotrophic Lateral Sclerosis epidemiology: Find out the number of
patients diagnosed (prevalence) with Amyotrophic Lateral Sclerosis in
the US
-- Amyotrophic Lateral Sclerosis drugs: Identify key products marketed and
prescribed for Amyotrophic Lateral Sclerosis in the US, including trade
name, molecule name, and company
-- Amyotrophic Lateral Sclerosis drugs sales: Find out the sales revenues
of Amyotrophic Lateral Sclerosis drugs in the US
-- Amyotrophic Lateral Sclerosis market valuations: Find out the market
size for Amyotrophic Lateral Sclerosis drugs in 2018 in the US. Find out
how the market advanced from 2014 and forecast to 2024
-- Amyotrophic Lateral Sclerosis drugs market share: Find out the market
shares for key Amyotrophic Lateral Sclerosis drugs in the US
Benefits of this Research
-- Support monitoring and reporting national Amyotrophic Lateral Sclerosis
market analysis and sales trends
-- Track competitor drugs sales and market share in the US Amyotrophic
Lateral Sclerosis market
-- Track competitive developments in Amyotrophic Lateral Sclerosis market
and present key issues and learnings
-- Synthesize insights for Amyotrophic Lateral Sclerosis market and
products to drive business performance
-- Answer key business questions about the Amyotrophic Lateral Sclerosis
market
-- Evaluate commercial market opportunity assessment, positioning, and
segmentation for Amyotrophic Lateral Sclerosis products
-- Supports decision making in R&D to long term marketing strategies
Key Topics Covered
1) Amyotrophic Lateral Sclerosis Treatments
2) Amyotrophic Lateral Sclerosis Pipeline
3) US Amyotrophic Lateral Sclerosis Epidemiology
4) Marketed Drugs for Amyotrophic Lateral Sclerosis in US
5) US Amyotrophic Lateral Sclerosis Market Size and Forecast
6) US Amyotrophic Lateral Sclerosis Products Sales and Forecast
7) US Amyotrophic Lateral Sclerosis Market Competitive Landscape
8) Methodology
List of Tables
1. Amyotrophic Lateral Sclerosis Phase 3 Clinical Trials, 2019
2. Amyotrophic Lateral Sclerosis Phase 2 Clinical Trials, 2019
3. Amyotrophic Lateral Sclerosis Phase 1 Clinical Trials, 2019
4. Amyotrophic Lateral Sclerosis Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Amyotrophic Lateral Sclerosis, US, 2018
6. Amyotrophic Lateral Sclerosis Market Size and Forecast ($), US, 2014 - 2024
7. Amyotrophic Lateral Sclerosis Product Sales ($), US, 2014 - 2024
List of Figures
1. Amyotrophic Lateral Sclerosis Epidemiology, US, 2014 - 2024
2. Amyotrophic Lateral Sclerosis Market Size and Forecast ($), US, 2014 - 2024
3. Amyotrophic Lateral Sclerosis Products Market Share (%), US, 2018
For more information about this report visit https://www.researchandmarkets.com/r/jz6p48
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/united-states-amyotrophic-lateral-sclerosis-als-market-report-2019-pipeline-epidemiology-market-valuations-drugs-sales-and-market-share-2014-2024-300883405.html
SOURCE Research and Markets
|
|
|
|
|
|
 |
Microsoft announces quarterly earnings release date | Apr 19, 2024
|
|
Cheetah Mobile Inc. Files Its Annual Report on Form 20-F | Apr 19, 2024
|
|
Expert.ai Launches Insight Engine for Life Sciences | Apr 19, 2024
|
|
My Size Announces Reverse Stock Split | Apr 19, 2024
|
|
New site speed metrics launch in the Lumar website intelligence platform | Apr 19, 2024
|
|
Invitation to Electrolux Group Q1 presentation | Apr 19, 2024
|
|
TransPerfect Wins Two Entertainment Globalization Association (EGA) Hermes Awards | Apr 19, 2024
|
|
NextPlat Announces Proposed Business Combination with Progressive Care Inc. | Apr 19, 2024
|
|
Select Registry is Recognized for Two IAC Awards in 2024 | Apr 19, 2024
|
|
The Aaron's Company, Inc. Announces First Quarter 2024 Earnings Call and Webcast | Apr 19, 2024
|
|
|
|
